Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04261855
Title Targeted Therapy and Avelumab in Merkel Cell Carcinoma (GoTHAM)
Acronym GoTHAM
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Melanoma and Skin Cancer Trials Limited
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS


No variant requirements are available.